Integrative Approach to Develop and Characterize Antibodies against the Cancer-Associated Antigen Sialyl Lewis A (CA 19-9). [PDF]
Freitag A +14 more
europepmc +1 more source
Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression. [PDF]
Trindade G, Palma AS, Brito C.
europepmc +1 more source
Glycoengineering strategies for constructing defined Mucin O-glycans. [PDF]
Jaroentomeechai T +3 more
europepmc +1 more source
Orosomucoid 2 (ORM2) in type 2 diabetes and coronary artery disease: a potential link between insulin resistance and vascular inflammation. [PDF]
Sun X, Tang X, Yuan G.
europepmc +1 more source
Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins. [PDF]
Al-Khreisat MJ +10 more
europepmc +1 more source
FUT2-mediated intestinal fucosylation: a master regulator of host-microbiota symbiosis in health and disease. [PDF]
Zhao L, Zhang N.
europepmc +1 more source
Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy. [PDF]
Guo Z +12 more
europepmc +1 more source
Parkinson's Disease-Associated Remodeling of Synaptic <i>N</i>-Glycans in the Human Prefrontal Cortex. [PDF]
Adeniyi M +7 more
europepmc +1 more source
Related searches:
Chemical Preparation of Sialyl Lewis x Using an Enzymatically Synthesized Sialoside Building Block
The sialyl Lewis x tetrasaccharide with a propylamine aglycon was assembled by chemoselective glycosylation from a p-tolyl thioglycosyl donor obtained from an enzymatically synthesized sialodisaccharide.
Xi Chen, Yanhong Li, Saddam M Muthana
exaly +2 more sources

